Devin L Brown1, Ashkan Mowla2, Mollie McDermott3, Lewis B Morgenstern4, Garnett Hegeman5, Melinda A Smith3, Nelda M Garcia3, Ronald D Chervin5, Lynda D Lisabeth4. 1. Stroke Program, University of Michigan, Ann Arbor, Michigan. Electronic address: devinb@umich.edu. 2. Department of Neurology, University at Buffalo, The State University of New York, Buffalo, New York. 3. Stroke Program, University of Michigan, Ann Arbor, Michigan. 4. Stroke Program, University of Michigan, Ann Arbor, Michigan; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan. 5. Sleep Disorders Center, University of Michigan, Ann Arbor, Michigan.
Abstract
BACKGROUND: Little is known about the prevalence of sleep-disordered breathing (SDB) across ischemic stroke subtypes. Given the important implications for SDB screening, we tested the association between SDB and ischemic stroke subtype in a population-based study. METHODS: Within the Brain Attack Surveillance in Corpus Christi Project, ischemic stroke patients were offered SDB screening with the ApneaLink Plus (n = 355). A neurologist assigned Trial of the ORG 10172 in Acute Stroke Treatment subtype (with an additional category for nonlacunar infarctions of unknown etiology) using hospital records. Unadjusted and adjusted (demographics, body mass index, National Institutes of Health Stroke Scale, diabetes, history of stroke/transient ischemic attack) logistic and linear regression models were used to test the association between subtype and SDB or apnea-hypopnea index (AHI). RESULTS: Median age was 65%, and 55% were men; 59% were Mexican American. Median time from stroke onset to SDB screen was 13 days (interquartile range [IQR] 6, 21). Overall, 215 (61%) had SDB (AHI ≥ 10). Median AHI was 13 (IQR 6, 27). Prevalence of SDB by subtype was cardioembolism, 66%; large-artery atherosclerosis, 57%; small-vessel occlusion, 68%; other determined, 50%; undetermined etiology, 58%; and nonlacunar stroke of unknown etiology, 63%. Ischemic stroke subtype was not associated with SDB in unadjusted (P = .72) or adjusted models (P = .91) models. Ischemic stroke subtype was not associated with AHI in unadjusted (P = .41) or adjusted models (P = .62). CONCLUSIONS: In this population-based stroke surveillance study, ischemic stroke subtype was not associated with the presence or severity of SDB. Sleep-disordered breathing is likely to be present after ischemic stroke, and the subtype should not influence decisions about SDB screening.
BACKGROUND: Little is known about the prevalence of sleep-disordered breathing (SDB) across ischemic stroke subtypes. Given the important implications for SDB screening, we tested the association between SDB and ischemic stroke subtype in a population-based study. METHODS: Within the Brain Attack Surveillance in Corpus Christi Project, ischemic strokepatients were offered SDB screening with the ApneaLink Plus (n = 355). A neurologist assigned Trial of the ORG 10172 in Acute Stroke Treatment subtype (with an additional category for nonlacunar infarctions of unknown etiology) using hospital records. Unadjusted and adjusted (demographics, body mass index, National Institutes of Health Stroke Scale, diabetes, history of stroke/transient ischemic attack) logistic and linear regression models were used to test the association between subtype and SDB or apnea-hypopnea index (AHI). RESULTS: Median age was 65%, and 55% were men; 59% were Mexican American. Median time from stroke onset to SDB screen was 13 days (interquartile range [IQR] 6, 21). Overall, 215 (61%) had SDB (AHI ≥ 10). Median AHI was 13 (IQR 6, 27). Prevalence of SDB by subtype was cardioembolism, 66%; large-artery atherosclerosis, 57%; small-vessel occlusion, 68%; other determined, 50%; undetermined etiology, 58%; and nonlacunar stroke of unknown etiology, 63%. Ischemic stroke subtype was not associated with SDB in unadjusted (P = .72) or adjusted models (P = .91) models. Ischemic stroke subtype was not associated with AHI in unadjusted (P = .41) or adjusted models (P = .62). CONCLUSIONS: In this population-based stroke surveillance study, ischemic stroke subtype was not associated with the presence or severity of SDB. Sleep-disordered breathing is likely to be present after ischemic stroke, and the subtype should not influence decisions about SDB screening.
Authors: Cother Hajat; Peter U Heuschmann; Catherine Coshall; Soundrie Padayachee; John Chambers; Anthony G Rudd; Charles D A Wolfe Journal: J Neurol Neurosurg Psychiatry Date: 2010-10-25 Impact factor: 10.154
Authors: Susan Redline; Gayane Yenokyan; Daniel J Gottlieb; Eyal Shahar; George T O'Connor; Helaine E Resnick; Marie Diener-West; Mark H Sanders; Philip A Wolf; Estella M Geraghty; Tauqeer Ali; Michael Lebowitz; Naresh M Punjabi Journal: Am J Respir Crit Care Med Date: 2010-03-25 Impact factor: 21.405
Authors: Paisith Piriyawat; Miriam Smajsová; Melinda A Smith; Sanjay Pallegar; Areej Al-Wabil; Nelda M Garcia; Jan M Risser; Lemuel A Moyé; Lewis B Morgenstern Journal: Am J Epidemiol Date: 2002-12-01 Impact factor: 4.897
Authors: Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner Journal: Circulation Date: 2017-01-25 Impact factor: 29.690
Authors: Lynda D Lisabeth; Brisa N Sánchez; Ronald D Chervin; Lewis B Morgenstern; Darin B Zahuranec; Susan D Tower; Devin L Brown Journal: Sleep Med Date: 2016-02-12 Impact factor: 3.492
Authors: Natalie C Wheeler; Jeffrey J Wing; Louise M O'Brien; Rebecca Hughes; Teresa Jacobs; Edward Claflin; Ronald D Chervin; Devin L Brown Journal: J Clin Sleep Med Date: 2016-09-15 Impact factor: 4.062
Authors: Devin L Brown; Chengwei Li; Brisa N Sánchez; Galit Levi Dunietz; Ronald D Chervin; Erin Case; Nelda M Garcia; Lynda D Lisabeth Journal: J Clin Sleep Med Date: 2018-05-15 Impact factor: 4.062
Authors: Devin L Brown; Kevin He; Sehee Kim; Chia-Wei Hsu; Erin Case; Ronald D Chervin; Lynda D Lisabeth Journal: Sleep Med Date: 2020-05-15 Impact factor: 3.492
Authors: Filip Alexiev; Anne-Kathrin Brill; Sebastian R Ott; Simone Duss; Markus Schmidt; Claudio L Bassetti Journal: J Thorac Dis Date: 2018-12 Impact factor: 2.895
Authors: Melissa C Lipford; Kelly D Flemming; Andrew D Calvin; Jay Mandrekar; Robert D Brown; Virend K Somers; Sean M Caples Journal: Sleep Date: 2015-11-01 Impact factor: 5.849
Authors: Mollie McDermott; Devin L Brown; Chengwei Li; Nelda M Garcia; Erin Case; Ronald D Chervin; Lewis B Morgenstern; Lynda D Lisabeth Journal: Sleep Med Date: 2017-12-06 Impact factor: 3.492